Dr. Reddy’s Laboratories received Voluntary Licence from Gilead to make the latest generation HIV drug, lenacapavir, accessible to patients in 120 countries Proud to announce that we have received a royalty-free non-exclusive voluntary licence from Gilead to make the latest generation HIV drug lenacapavir accessible to patients in 120 countries! This marks an important milestone … Read more
Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases. Amneal to construct state-of-the-art manufacturing facilities and utilize existing manufacturing network to ensure supply of Metsera’s portfolio of novel injectable and oral development programs, including GLP-1 and amylin receptor agonists Agreement provides Amneal with a new … Read more
Alkem Laboratories denies claims of Pan-D, Clavam 625 batches being not-of-standard quality The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem Alkem gives utmost importance to quality and patient safety. All products manufactured at our sites follow the current good manufacturing practices (cGMP) Alkem Laboratories Ltd. (BSE: … Read more
Amneal Pharmaceuticals, Inc. announced that it has received Abbreviated New Drug Application (“ANDA”) approval from the U.S. Food and Drug Administration (FDA) for Propofol Injectable Emulsion USP, 200 mg/20 mL (10 mg/mL), 500 mg/50 mL (10 mg/mL), and 1,000 mg/100 mL (10 mg/mL), Single-Dose Vials. Propofol is an intravenous drug commonly used in hospitals for … Read more
BioMatrix Healthcare Pvt. Ltd announced that OSD facility has received EUGMP approval!This achievement is a testament to unwavering dedication and commitment of our Team. The journey has just begun, many more milestones to achieve.- Team BioMatrix Healthcare Pvt. Ltd. was established in the year 2007 with a thought of “Supporting Life Worldwide” and each of … Read more
